ANNOUNCEMENT

Pharmacotherapy Publications is pleased to announce the launch of a new web site, using the Atypon Premium platform. The new web site will combine the functions of the Atypon-Link site which hosts the online journal and this site. During our transition period of April 2011, both sites will be available to subscribers. The new site may be reached at this link:
Current Issue: April 2011
PHARMACOTHERAPY VOLUME 31, NUMBER 4

EDITORIAL

Place of Dabigatran in Contemporary Pharmacotherapy
John G. Gums, Pharm.D., FCCP

ORIGINAL RESEARCH ARTICLES

Clinical and Microbiologic Outcomes in Trauma Patients Treated for Stenotrophomonas maltophilia Ventilator-Associated Pneumonia
Quinn A. Czosnowski, Pharm.D., G. Christopher Wood, Pharm.D., Louis J. Magnotti, M.D., Martin A. Croce, M.D., Joseph M. Swanson, Pharm.D., Bradley A. Boucher, Pharm.D., and Timothy C. Fabian, M.D.

Improving Prescribing Safety in Patients with Renal Insufficiency in the Ambulatory Setting: The Drug Renal Alert Pharmacy (DRAP) Program
Bharati Bhardwaja, Pharm.D., Nikki M. Carroll, M.S., Marsha A. Raebel, Pharm.D., Elizabeth A. Chester, Pharm.D., M.P.H., Eli J. Korner, Pharm.D., M.P.H., Bob E. Rocho, B.S., David W. Brand, M.S.P.H., and David J. Magid, M.D., M.P.H.

REVIEWS OF THERAPEUTICS

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances: Insights from the Society of Infectious Diseases Pharmacists
 Paulina Deming, Pharm.D., and Ian R. McNicholl, Pharm.D.

Empiric Antifungal Therapy in Patients with Febrile Neutropenia
Jenna J. Ferrara, Pharm.D., Conan MacDougall, Pharm.D., M.A.S., and Jason C. Gallagher, Pharm.D.

Brand Name versus Generic Warfarin: A Systematic Review of the Literature
Francesco Dentali, M.D., Marco P. Donadini, M.D., Nathan Clark, Pharm.D., Mark A. Crowther, M.D., David Garcia, M.D., Elaine Hylek, M.D., Dan M. Witt, Pharm.D., and Walter Ageno, M.D., for the Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium

Belatacept: A Novel Biologic for Maintenance Immunosuppression After Renal Transplantation
 Spencer T. Martin, Pharm.D., Eric M. Tichy, Pharm.D., and Steven Gabardi, Pharm.D.

Epileptogenic Potential of Carbapenem Agents: Mechanism of Action, Seizure Rates, and Clinical Considerations
April D. Miller, Pharm.D., Amanda M. Ball, Pharm.D., P. Brandon Bookstaver, Pharm.D., Emily K. Dornblaser, Pharm.D., and Charles L. Bennett, M.D., Ph.D.

PRN OPINION PAPER

Changing Oral Contraceptives from Prescription to Over-the-Counter Status: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy
Jennifer McIntosh, Pharm.D., M.H.S., Sally Rafie, Pharm.D., Mitzi Wasik, Pharm.D., Sarah McBane, Pharm.D., Nicole M. Lodise, Pharm.D., Shareen Y. El-Ibiary, Pharm.D., Alicia Forinash, Pharm.D., Marlowe Djuric Kachlic, Pharm.D., Emily Rowe, Pharm.D., and Kathy Besinque, Pharm.D., M.S.Ed., FASHP

CASE REPORTS

Pharmacokinetics of the Long-Acting, First-Generation Antipsychotic Fluphenazine
Tara L. Purvis, Pharm.D., Robin N. Hieber, Pharm.D., Timothy Dellenbaugh, M.D., and Roger W. Sommi, Pharm.D., FCCP

Therapeutic Drug Monitoring in Patients Coinfected with Human Immunodeficiency Virus and Disseminated Mycobacterium avium Complex
Keith J. Dunn, Pharm.D., Paul R. Skolnik, M.D., Leyla Azis, M.D., and Helene Hardy, Pharm.D.

Levetiracetam-Induced Acute Generalized Exanthematous Pustulosis
Said M. Sultan, Pharm.D., and Lindsay M. Daniels, Pharm.D.